A new website from Albert Einstein College of Medicine at Yeshiva University—SuperAgers.com—highlights the findings from more than a decade of aging research and features some of the centenarians that shared their secrets, and their DNA, for this seminal project.
SuperAgers.com helps us understand the current state of aging science, the genetics of aging, and the tremendous potential for useful aging interventions. It also lets us hear the personal stories of individuals who are living longer and loving it.
Investigators supported by the National Institute on Aging (NIA) are on the cusp of research breakthroughs that could enhance their abilities to predict and intervene earlier in the processes of many age-related chronic diseases. In particular, rapid progress in recent years in advancing understanding of the aging process has led to considerable knowledge of how scientists might increase human health in later life by opposing the primary risk factor for most disease of aging—aging itself.
Exciting treatments make slowing and even restoring vision loss in wet age-related macular degeneration (wAMD) patients a reality. Two of the most frequently used treatments are currently in the spotlight as they go head-to-head in clinical trials comparing their effectiveness, and to some extent, exploring their costs.
Each year, as many as 5 million Americans are diagnosed with valve disease. There are a number of different types of valve disease and all of them involve defects or damage to one or more of the heart’s four valves. While some types are not serious, others can lead to major complications, including death. Fortunately, most valve disease can be successfully treated with surgery in patients of all ages and races.